HEPATOCELLULCAR CARCINOMA
Clinical trials for HEPATOCELLULCAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULCAR CARCINOMA trials appear
Sign up with your email to follow new studies for HEPATOCELLULCAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver cancer: drug combo targets tumors resistant to immunotherapy
Disease control Recruiting nowThis study is for people with advanced liver cancer that has stopped responding to standard immunotherapy. It tests a new combination of two drugs (dalpiciclib and camrelizumab) to see if they can shrink tumors or slow the disease. About 30 participants will receive the treatment…
Matched conditions: HEPATOCELLULCAR CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New hope for liver cancer patients when first treatment fails
Disease control Recruiting nowThis study is for people with advanced liver cancer whose first treatment (bevacizumab plus sintilimab) stopped working. It compares two second-line options: adding lenvatinib to the current regimen or switching to regorafenib plus a PD-1 inhibitor. The goal is to see which appro…
Matched conditions: HEPATOCELLULCAR CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC